These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 834763)

  • 1. [Combination therapy with butomelide and rifampicin in experimental tuberculosis in albino mice].
    Pershin GN; Zykova TN; Kutchak SN
    Probl Tuberk; 1977 Jan; (1):64-9. PubMed ID: 834763
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative data from an experimental-clinical study of new antituberculosis drugs].
    Utkin VV
    Antibiotiki; 1972 Sep; 17(9):851-6. PubMed ID: 4631726
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rifampicin in the treatment of chronic pulmonary tuberculosis].
    Pacheco CR; Cordero O; Sierra D; Pacheco J; Vázquez E
    Gac Med Mex; 1976 Jun; 107(6):505-11. PubMed ID: 976671
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rifampicin in the treatment of newly detected destructive pulmonary tuberculosis].
    Khomenko AG; Chukanov VI
    Probl Tuberk; 1978 Jun; (6):14-20. PubMed ID: 353801
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of rifampicin in venous perfusion in tuberculosis].
    Perna G; Natale F
    Clin Ter; 1979 Jul; 90(1):63-73. PubMed ID: 535329
    [No Abstract]   [Full Text] [Related]  

  • 6. Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection.
    Yu WC; Lai ST; Chiu MC; Chau TN; Ng TK; Tam CM
    Int J Tuberc Lung Dis; 2006 Jul; 10(7):824-5. PubMed ID: 16850548
    [No Abstract]   [Full Text] [Related]  

  • 7. [Possibility to shorten the treatment of the newly detected patients with tuberculosis through continuous and intermittent application of rifampicin, myambutol and isoniasid (author's transl)].
    Grujić M; Djurisić M; Mihajlović V; Jeremić V; Arsenijević V; Popovac D; Nikolić D; Radotić M; Jonev P; Nale P
    Plucne Bolesti Tuberk; 1977; 29(2):8-12. PubMed ID: 859943
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of treatment with rifampicin in 39 patients hospitalized in our service during 1970-1971-1972].
    Maalej M; Chabbou A; Zbiba M; El Gharbi B; Halfon S; El Gharbi T; Cheniti M; El Mekki L; Djen Ayah F; Chebbi ML; Jeguirim M; Ben Salah M
    Tunis Med; 1974; 52(6):313-6. PubMed ID: 4619937
    [No Abstract]   [Full Text] [Related]  

  • 9. Bacteriologic basis of short-course chemotherapy for tuberculosis.
    Grosset J
    Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
    [No Abstract]   [Full Text] [Related]  

  • 10. [Double antibacterial therapy in untreated tuberculosis. Retrospective study of 120 unselected patients treated between 1972 and 1974].
    Augé C; Lecocguic Y; Touaty E; Bussi S; Pariente R
    Rev Fr Mal Respir; 1982; 10(6):391-9. PubMed ID: 6819611
    [No Abstract]   [Full Text] [Related]  

  • 11. [Place of rifampicin in the treatment of pulmonary tuberculosis].
    Despierres G; Bonnet PA; Phélip H
    J Med Lyon; 1971 Jun; 52(210):893-4 passim. PubMed ID: 5132687
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of treatment of chronically infectious patients with rifampicin in various combinations and in various models].
    Górecki R; Stanek S
    Gruzlica; 1974 May; 42(5):411-6. PubMed ID: 4464229
    [No Abstract]   [Full Text] [Related]  

  • 13. [Principles of rational tuberculosis chemotherapy].
    Khomenko AG
    Antibiotiki; 1980 Jul; 25(7):534-9. PubMed ID: 7406466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A new antitubercular agent: rifampicin].
    Favez G
    Schweiz Rundsch Med Prax; 1970 Feb; 59(8):296-7. PubMed ID: 4996719
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombocytopenia--a rare but serious side effect of rifampicin.
    Shah NM; Venkatachalam S; Mehta Y; Balakrishnan C; Dubey SG; Mangat GK; Joshi VR
    J Assoc Physicians India; 1996 May; 44(5):359-60. PubMed ID: 9282598
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined treatment with rifampicin-ethambutol-capreomycin in chronic open pulmonary tuberculosis.
    Virchow C; Flemming J
    Acta Tuberc Pneumol Belg; 1969; 60(3):466-70. PubMed ID: 5371671
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy for tuberculosis.
    Lester W
    Postgrad Med; 1976 Sep; 60(9):112-7. PubMed ID: 959073
    [No Abstract]   [Full Text] [Related]  

  • 18. The advantages of the antituberculosis regimens which include Sinerdol-EH, a new tuberculostatic of rifampicin-type.
    Păunescu E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983; 32(1):33-42. PubMed ID: 6312533
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral solid lipid nanoparticle-based antitubercular chemotherapy.
    Pandey R; Sharma S; Khuller GK
    Tuberculosis (Edinb); 2005; 85(5-6):415-20. PubMed ID: 16256437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative characteristics of the use of rifadin and ethambutol in the complex treatment of patients with fibro-cavernous pulmonary tuberculosis].
    Tarasova EF; Sagalovich VIa
    Probl Tuberk; 1974; (12):26-30. PubMed ID: 4445131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.